Improved Chemosensitivity in Metastatic Castration‐Resistant Prostate Cancer: The Synergistic Effects of S‐Adenosylmethionine and Cabazitaxel

Documenti analoghi

• Heterogeneity in Treatment Effects of Reduced Versus Standard Dose of Cabazitaxel in Metastatic Castration‐Resistant Prostate Cancer
  di: Wataru Fukuokaya, et al.
  Pubblicazione: (2026)
• Number of Prescription Medications and Overall Survival in Metastatic Castrate‐Resistant Prostate Cancer
  di: Carley R. Pickett, et al.
  Pubblicazione: (2024)
• Effectiveness and Safety of Radium‐223 for Bone‐Metastatic Castration‐Resistant Prostate Cancer: The KYUCOG ‐1901 Study
  di: Masaki Shiota, et al.
  Pubblicazione: (2025)
• Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (CRPC) Patients: CaPA Study
  di: Pedro Costa, et al.
  Pubblicazione: (2025)
• Integrating NLP to Enhance Algorithmic Identification of Metastatic and Castration‐Resistant Prostate Cancer in Large Claims‐Based Studies
  di: Shannon R. Stock, et al.
  Pubblicazione: (2025)